← Leaderboards
Matthew A Powell
Washington University
$1,062,366
Attributed
$2,979,619
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $522.5K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,979,619 · 2
By mechanism
R01$2,564,660 · 1
P50$414,959 · 1
Top collaborators
- Cary L Siegel5 shared
- Quing Zhu5 shared
- Pamela M Pollock3 shared
Most similar at Washington University
Same institution · by research overlap
- Paul Joseph Goodfellow$8,639,266
- Quing Zhu$6,933,345
- Timothy J Eberlein$71,591,509
- Cary L Siegel$854,887
- Gerald Louis Andriole$6,419,713
Others in their field
Top investigators on “Modality”
- Charles A Coltman · Southwest Oncology Group$185,443,433
- Peter B. Gilbert · Fred Hutchinson Cancer Center$167,167,617
- Philip J Disaia · University Of California Irvine$144,322,261
- Richard L Schilsky · University Of Chicago$117,759,216
- Kimberly Smith · Ppd Development Lp$115,671,664
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$95,994,777
Research focus
ModalityAngiogenesisWomanChemotherapyMalignant NeoplasmsStandard Of CareMorbidity - Disease RateTumorAdvanced DiseaseDoppler UltrasoundEffectivenessEarly DiagnosisBenignBiological MarkersEmerging TechnologiesCostClinical PracticeDevicesCancer DetectionCancer DiagnosisCancer RiskAbsorptionAcousticsAccurate Diagnosis
Grant awards (8)
Coregistered Photoacoustic and Ultrasound Imaging for Ovarian Cancer Diagnosis and Risk Management$496,379
R01 · FY2024 · CA
Coregistered Photoacoustic and Ultrasound Imaging for Ovarian Cancer Diagnosis and Risk Management$512,052
R01 · FY2023 · CA
Coregistered Photoacoustic and Ultrasound Imaging for Ovarian Cancer Diagnosis and Risk Management$512,052
R01 · FY2022 · CA
Coregistered Photoacoustic and Ultrasound Imaging for Ovarian Cancer Diagnosis and Risk Management$522,503
R01 · FY2021 · CA
Coregistered Photoacoustic and Ultrasound Imaging for Ovarian Cancer Diagnosis and Risk Management$521,674
R01 · FY2020 · CA
FGFR2 as a Therapeutic Target in Endometrial Cancer.$152,452
P50 · FY2011 · CA
FGFR2 as a Therapeutic Target in Endometrial Cancer.$156,607
P50 · FY2010 · CA
FGFR2 as a Therapeutic Target in Endometrial Cancer.$105,900
P50 · FY2009 · CA